The Importance of Incorporating OCT2 Plasma Membrane Expression and Membrane Potential in IVIVE of Metformin Renal Secretory Clearance
- 1 October 2018
- journal article
- research article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 46 (10) , 1441-1445
Abstract
Transporter expression, determined by quantitative proteomics, together with PBPK models is a promising approach for in-vitro to in-vivo extrapolation (IVIVE) of transporter-mediated drug clearance. OCT2-expressing HEK293 and MDCKII cells were used to predict in-vivo renal secretory clearance (CLr,sec) of metformin. [14C]-Metformin uptake clearance in OCT2-expressing cells was determined and scaled to in-vivo CLr,sec by using OCT2-expression in the cells vs. the human kidney cortex. Using quantitative targeted proteomics, the total expression of OCT2 in HEK293, MDCKII cells and human kidney cortex was 369.4±26.8, 19±1.1 and 7.6±3.8 pmol/mg cellular protein, respectively. The expression of OCT2 in the plasma membrane of HEK293 and MDCKII cells, measured using an optimized biotinylation method followed by quantitative proteomics, was 30.2% and 51.6%, respectively. After correcting for percent of OCT2 expressed in the plasma membrane and the resting membrane potential (mV) difference between the OCT2-expressing cells and the renal epithelial cells, the predicted CLr,sec of metformin was 250.7 mL/min, a value within the range of the observed CLr,sec of metformin. These data demonstrate the promise of using quantitative proteomics for IVIVE of drug clearance and highlight the importance of quantifying plasma membrane expression of transporters and utilizing cells that mimic the in-vivo mechanism(s) of transport of drugs.Keywords
This publication has 24 references indexed in Scilit:
- Quantitative Structure-Pharmacokinetic Relationships for the Prediction of Renal Clearance in HumansDrug Metabolism and Disposition, 2015
- Predicting carrier-mediated hepatic disposition of rosuvastatin in man by scaling from individual transfected cell-lines in vitro using absolute transporter protein quantification and PBPK modelingEuropean Journal of Pharmaceutical Sciences, 2014
- Comparison of In Vitro-In Vivo Extrapolation of Biliary Clearance Using an Empirical Scaling Factor Versus Transport-Based Scaling Factors in Sandwich-Cultured Rat HepatocytesJournal of Pharmaceutical Sciences, 2013
- Mechanistic Pharmacokinetic Modeling for the Prediction of Transporter-Mediated Disposition in Humans from Sandwich Culture Human Hepatocyte DataDrug Metabolism and Disposition, 2012
- Prediction of Human Renal Clearance from Preclinical Species for a Diverse Set of Drugs That Exhibit Both Active Secretion and Net ReabsorptionDrug Metabolism and Disposition, 2011
- Effects of a MATE Protein Inhibitor, Pyrimethamine, on the Renal Elimination of Metformin at Oral Microdose and at Therapeutic Dose in Healthy SubjectsClinical Pharmacology & Therapeutics, 2011
- Membrane Potential Depolarization as a Triggering Mechanism for Vpu-Mediated HIV-1 ReleaseBiophysical Journal, 2010
- Baculoviruses and Mammalian Cell‐based Assays for Drug Screening2006
- Molecular and Cellular Physiology of Renal Organic Cation and Anion TransportPhysiological Reviews, 2004
- Properties and regulation of ion channels in MDCK cellsKidney International, 1995